• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Top Stories for the Week of November 13th, 2006

Top Stories for the Week of November 13th, 2006

November 13, 2006
CenterWatch Staff

Top News

UBC Buys Biostatistical and Medical Writing Firm BioCor

Maryland-based clinical trial design, and data management and consulting company United BioSource Corporation (UBC) has acquired BioCor LLC, a biostatistical, data services and medical writing firm based in Yardley, Pa. One of BioCor's specialties is designing trial protocols with advanced biostatistical methods for emerging biotech companies. It will be the first business unit in what is to become UBC's Biotechnology Solutions Group.

UK Aims to Speed up Trials with One-Stop NHS Review Process

Hospitals within the UK's National Healthcare System (NHS) can now benefit from a revision of the country's Model Clinical Trial Agreement rules, which include the trial site review process. Under the new system, only one review would be necessary for industry-sponsored trials taking place within the NHS network, where previously each site required individual clearance. The study must get approval from the Medicines and Healthcare products Regulatory Agency (MHRA) before the review process can begin.

Other breaking news...

  • Qualia in strategic alliance with Tandem Labs...
  • eResearch Technology reports lower than expected third quarter earnings...
    

Company Profile: An interview with Jordi Naval, managing director, Infociencia.

To read the full articles for this issue or for more information on these and other breaking stories, please click here!

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Virtual Doctoer

    Simple Changes Can Make Trials More Patient Friendly

  • Drug approval

    Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.

  • VaccinewithNeedle-360x240.png

    Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant

  • AskTheExperts-360x240.png

    Ask the Experts: Trial Operations Adjustments in a Remote World

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing